William Blair research analyst Matt Phipps returned as a guest on Biotech TV where he discussed the stocks of sector companies Janux, NewAmsterdam, Jasper, Autolus, Incyte, Merus, and Amgen.
Equity Research
Matt Phipps Joins Biotech TV
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
Tempus AI, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Tempus AI, Inc. (TEM $30.88), a company that provides precision medicine solutions for patients and uses its data platform to offer insights for researchers and pharma companies.
Read moreThe Emerging Shift in Economic Growth Drivers
In this week’s Economics Weekly, William Blair Macro Analyst Richard de Chazal reexamines America’s trajectory and what this could mean for the structure of growth dynamics going forward.
Read more